PURE Biosciences

PURE · OTC

$0.072+$0.0059 (+8.93%)TodayMarket closed · Oct 20, 3:58 PM ET

Prev close $0.0661

Latest news

Press releaseJun 15, 4:05 PM ETBusiness Wire
PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results
Press releaseMar 16, 4:05 PM ETBusiness Wire
PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results
Press releaseDec 15, 4:05 PM ETBusiness Wire
PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results
Press releaseNov 19, 4:05 PM ETBusiness Wire
PURE Bioscience, Inc. Announces Leadership Promotions
Press releaseOct 29, 4:05 PM ETBusiness Wire
PURE Bioscience Reports Fiscal 2025 Financial Results
Press releaseJun 26, 9:00 AM ETBusiness Wire
PURE Bioscience Partners with Bonsai for Direct-to-Customer Sales
Press releaseJun 16, 4:05 PM ETBusiness Wire
PURE Bioscience Reports Fiscal Third Quarter 2025 Financial Results
Press releaseJun 2, 5:21 PM ETBusiness Wire
PURE Bioscience Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage Industry
Press releaseMar 17, 4:05 PM ETBusiness Wire
PURE Bioscience Reports Fiscal Second Quarter 2025 Financial Results
Press releaseJan 21, 3:05 PM ETBusiness Wire
PURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company
Press releaseJan 9, 3:02 PM ETBusiness Wire
PURE Bioscience Unveils New Brand Identity
Press releaseDec 16, 4:05 PM ETBusiness Wire
PURE Bioscience Reports Fiscal First Quarter 2025 Financial Results
Press releaseNov 20, 9:00 AM ETBusiness Wire
PURE Bioscience Announces Distribution Agreement with AFCO, a Zep Company
Press releaseNov 1, 9:00 AM ETBusiness Wire
PURE Bioscience Announces Distribution Agreement with Quip Laboratories
Press releaseOct 29, 4:05 PM ETBusiness Wire
PURE Bioscience Reports Fiscal 2024 Financial Results
Press releaseOct 22, 1:00 PM ETBusiness Wire
PURE Bioscience Announces Distribution Agreement with Madison Chemical Co., Inc.
Press releaseOct 9, 9:00 AM ETBusiness Wire
PURE Bioscience Announces Distribution Agreement with Zee Company
Press releaseAug 1, 2:02 PM ETBusiness Wire
PURE Bioscience Announces Distribution Agreement with ChemStation

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results

PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results

PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results

PURE Bioscience, Inc. Announces Leadership Promotions

PURE Bioscience Reports Fiscal 2025 Financial Results

PURE Bioscience Partners with Bonsai for Direct-to-Customer Sales

PURE Bioscience Reports Fiscal Third Quarter 2025 Financial Results

PURE Bioscience Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage Industry

PURE Bioscience Reports Fiscal Second Quarter 2025 Financial Results

PURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company

PURE Bioscience Unveils New Brand Identity

PURE Bioscience Reports Fiscal First Quarter 2025 Financial Results

PURE Bioscience Announces Distribution Agreement with AFCO, a Zep Company

PURE Bioscience Announces Distribution Agreement with Quip Laboratories

PURE Bioscience Reports Fiscal 2024 Financial Results

PURE Bioscience Announces Distribution Agreement with Madison Chemical Co., Inc.

PURE Bioscience Announces Distribution Agreement with Zee Company

PURE Bioscience Announces Distribution Agreement with ChemStation